Pryor K O, Root J C, Mehta M, Stern E, Pan H, Veselis R A, Silbersweig D A
Department of Anesthesiology, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA Department of Anesthesia and Critical Care, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
Department of Anesthesiology, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA Department of Anesthesia and Critical Care, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Br J Anaesth. 2015 Jul;115 Suppl 1(Suppl 1):i104-i113. doi: 10.1093/bja/aev038.
Subclinical doses of propofol produce anterograde amnesia, characterized by an early failure of memory consolidation. It is unknown how propofol affects the amygdala-dependent emotional memory system, which modulates consolidation in the hippocampus in response to emotional arousal and neurohumoral stress. We present an event-related functional magnetic resonance imaging study of the effects of propofol on the emotional memory system in human subjects.
Thirty-five healthy subjects were randomized to receive propofol, at an estimated brain concentration of 0.90 μg ml(-1), or placebo. During drug infusion, emotionally arousing and neutral images were presented in a continuous recognition task, while blood-oxygen-level-dependent activation responses were acquired. After a drug-free interval of 2 h, subsequent memory for successfully encoded items was assessed. Imaging analysis was performed using statistical parametric mapping and behavioural analysis using signal detection models.
Propofol had no effect on the stereotypical amygdalar response to emotional arousal, but caused marked suppression of the hippocampal response. Propofol caused memory performance to become uncoupled from amygdalar activation, but it remained correlated with activation in the posterior hippocampus, which decreased in proportion to amnesia.
Propofol is relatively ineffective at suppressing amygdalar activation at sedative doses, but abolishes emotional modulation and causes amnesia via mechanisms that commonly involve hyporesponsiveness of the hippocampus. These findings raise the possibility that amygdala-dependent fear systems may remain intact even when a patient has diminished memory of events. This may be of clinical importance in the perioperative development of fear-based psychopathologies, such as post-traumatic stress disorder.
NCT00504894.
亚临床剂量的丙泊酚可产生顺行性遗忘,其特征为记忆巩固早期失败。丙泊酚如何影响杏仁核依赖的情绪记忆系统尚不清楚,该系统可响应情绪唤醒和神经体液应激调节海马体中的记忆巩固。我们开展了一项关于丙泊酚对人类受试者情绪记忆系统影响的事件相关功能磁共振成像研究。
35名健康受试者被随机分为两组,分别接受估计脑浓度为0.90μg/ml的丙泊酚或安慰剂。在药物输注期间,在连续识别任务中呈现情绪唤醒和中性图像,同时获取血氧水平依赖的激活反应。在2小时的无药间隔后,评估对成功编码项目的后续记忆。使用统计参数映射进行成像分析,使用信号检测模型进行行为分析。
丙泊酚对情绪唤醒时典型的杏仁核反应无影响,但显著抑制了海马体反应。丙泊酚使记忆表现与杏仁核激活脱钩,但仍与海马体后部的激活相关,海马体后部的激活与遗忘成比例下降。
在镇静剂量下,丙泊酚抑制杏仁核激活的效果相对较差,但通过通常涉及海马体反应性降低的机制消除了情绪调节并导致遗忘。这些发现增加了一种可能性,即即使患者对事件的记忆减弱,杏仁核依赖的恐惧系统可能仍然完好。这在基于恐惧的精神病理学(如创伤后应激障碍)的围手术期发展中可能具有临床重要性。
NCT00504894。